Literature DB >> 1550505

Evaluation of TRISS as a means of selecting trauma deaths for clinical peer review.

D A Hill1, A F Lennox, M J Neil, J P Sheehy.   

Abstract

This study was carried out to evaluate the predictive power of a mathematical model called TRISS in identifying avoidable trauma deaths when compared with peer review (PR). The subjects studied comprised the 24 deaths that occurred among 81 severely injured patients (Injury Severity Score greater than or equal to 16) admitted to a trauma unit over a 1 year period. Sixteen patients who had a greater than 50% probability of survival (Ps) calculated by TRISS died. Peer review concluded that five of those were potentially avoidable deaths. Eight deaths occurred in patients with a Ps less than 50%. Peer review regarded those eight as inevitable deaths. The data, when analysed, showed TRISS to have a 100% sensitivity, 42% specificity, 31% positive predictive value and a negative predictive value of 100% when compared with peer review. It is concluded that TRISS tends to over-estimate potentially avoidable death, especially in patients with severe head injury. However it is a good audit filter as it reliably excludes inevitable death.

Entities:  

Mesh:

Year:  1992        PMID: 1550505     DOI: 10.1111/j.1445-2197.1992.tb05464.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  4 in total

1.  Trauma outcomes: a death analysis study.

Authors:  M Sugrue; M Seger; D Sloane; J Compton; K Hillman; S Deane
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

2.  Studies of avoidable factors influencing death: a call for explicit criteria.

Authors:  R Westerling
Journal:  Qual Health Care       Date:  1996-09

3.  A computational model of information retrieval with UMLS.

Authors:  J J Robert; M Joubert; L Nal; M Fieschi
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1994

4.  Scoring systems in trauma.

Authors:  R Kingston; S J O'Flanagan
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 2.089

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.